Food and Drug Administration Drug Safety Podcast
Due to risk of serious liver injury, FDA restricts use of obeticholic acid (Ocaliva) in primary biliary cholangitis (PBC) patients with advanced cirrhosis
- Autor: Podcast
- Narrador: Podcast
- Editora: Podcast
- Duração: 0:03:00
- Mais informações
Informações:
Sinopse
Listen to FDA Drug Safety Podcast on due to risk of serious liver injury, FDA restricts use of Ocaliva in primary biliary cholangitis (PBC) patients with advanced cirrhosis
